ARCHIVES

In Brief: David Feigal To Head FDA’s Antiviral Division; ODAC To Discuss Melphalan, Amifostine NDAs

This article is from The Cancer Letter archive.

Vol. 18 No. 03 | January 17, 1992

Download PDF Visit The Full Archive

Related Articles

NCI Would Fund 3,164 research Project Grants, 897 Competition, Under FY92 While House Budget

February 15, 1991

Becker, Brown Testify On Biomedical Funding, Manpower Needs

March 23, 1990

Albino African Skin Cancer Study To Be Reevaluated

April 11, 1980

DCT Advisors OK 4 Contract Concepts In Therapeutics

June 28, 1991

NCI By Pass Budget For FY 1987 Is $1.57 Bil.

October 18, 1985

Chemoprevention Clinical Trial RFA Being Developed For January Concept Review, Along With “Bridge” RFA

November 27, 1981